Hey guys,
This has been on my mind for a while, and I've been trying to figure out why some psychedelics that were such a boom fell out of business due to being banned, but similar ones didn't 2C-[E/I/D/P/iP/C] got banned and the production stopped, but not for 2C-B. 2C-B and 2C-C share almost identical syntheses and precursors as well, so why not provide the option of 2C-C on DNMs? Yet I haven't come across it on DNMs in many years. The same goes for N-benzylalted phyenthylamines, more 3,4,5-trisubstituted phenethylamines (think mescaline and friends), interesting lysergamides like the LADs and LSP[/B/Z/M], I could go on and on too about how benzo diversity is quite low when really the slight precursor shifts necessary to broaden what's available are incredibly easy.
Why was the golden age of RCs in the past if nowadays some ket chemist could create MXE and make an absolute fortune, or a 2C-B chemist could start creating DOB, DOC, 2C-B, 2C-C, their -NBOH, -NBMD and -NBOMe variants, and maybe some simple things such as Shulgin's essential amphetamines (TMA-2, DMMDA, DMMDA-2, MMDA-2, MMDA-3a, MMDA, etc.). Hell, even 2C-T-X's can be trivially synthesized from 2C-B which is wildely available right now, so why hasn't it returned to the market?
Do you guys think that it's just because psychedelic markets aren't as highly profiting as say, 3-MMC/4-MMC/Methamphetamine/Amphetamine/Cocaine/Fent markets?
Just generally wondering if there are any known of reasons that only a few RCs make it into the mainstream over time. I feel like DOM, 2C-B, 4-AcO-DMT, NEP and 4-MMC are some examples of RCs that "graduted" in a way into the world of "real drugs", if that makes any sense.
Interested to hear peoples' takes on this, I wasn't around for the major RC golden age so I'm very curious about what people may know about what led to its downfall in general. I'm also interested to hear about peoples' takes on non-RC psychedelics that are difficult to acquire in a meaningful amount of doses, such as mescaline and ibogaine.
This has been on my mind for a while, and I've been trying to figure out why some psychedelics that were such a boom fell out of business due to being banned, but similar ones didn't 2C-[E/I/D/P/iP/C] got banned and the production stopped, but not for 2C-B. 2C-B and 2C-C share almost identical syntheses and precursors as well, so why not provide the option of 2C-C on DNMs? Yet I haven't come across it on DNMs in many years. The same goes for N-benzylalted phyenthylamines, more 3,4,5-trisubstituted phenethylamines (think mescaline and friends), interesting lysergamides like the LADs and LSP[/B/Z/M], I could go on and on too about how benzo diversity is quite low when really the slight precursor shifts necessary to broaden what's available are incredibly easy.
Why was the golden age of RCs in the past if nowadays some ket chemist could create MXE and make an absolute fortune, or a 2C-B chemist could start creating DOB, DOC, 2C-B, 2C-C, their -NBOH, -NBMD and -NBOMe variants, and maybe some simple things such as Shulgin's essential amphetamines (TMA-2, DMMDA, DMMDA-2, MMDA-2, MMDA-3a, MMDA, etc.). Hell, even 2C-T-X's can be trivially synthesized from 2C-B which is wildely available right now, so why hasn't it returned to the market?
Do you guys think that it's just because psychedelic markets aren't as highly profiting as say, 3-MMC/4-MMC/Methamphetamine/Amphetamine/Cocaine/Fent markets?
Just generally wondering if there are any known of reasons that only a few RCs make it into the mainstream over time. I feel like DOM, 2C-B, 4-AcO-DMT, NEP and 4-MMC are some examples of RCs that "graduted" in a way into the world of "real drugs", if that makes any sense.
Interested to hear peoples' takes on this, I wasn't around for the major RC golden age so I'm very curious about what people may know about what led to its downfall in general. I'm also interested to hear about peoples' takes on non-RC psychedelics that are difficult to acquire in a meaningful amount of doses, such as mescaline and ibogaine.